References
- Edelson R L, Berger C L, Gasparro F, Jegasothy B, Heald P, Wintroub B, et al. Treatment of cutaneous T cell lymphoma by extracorporeal photchemotherapy. N Engl J Med 1987; 316: 287–303
- Zic J, Arzubiaga C, Salhany K E, Parker R A, Wilson D, Strickland G P, et al. Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma. J Am Acad Dermatol 1992; 27: 729–736
- Duvic M, Chiao N, Talpur R. Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma. J Cutan Med Surg 2003; 7: 3–7
- Girardi M, Berger C L, Wilson L D, Christensen I R, Thompson K R, Glusac E J, Edelson R L. Transimmunization for cutaneous T cell lymphoma: A Phase I study. Leuk Lymphoma 2006; 47: 1495–1503
- Berger C L, Mariwalla K, Girardi M, Edelson R L. Advances in understanding the immunobiology and immunotherapy of cutaneous T-cell lymphoma. Adv Dermatol 2004; 20: 217–235
- Duvic M. Response rates in photopheresis therapy for cutaneous T cell lymphoma. Response letter. J Am Acad Dermatol 1997; 37: 288
- Jackow C M, Cather J C, Hearne V, Asano A, Musser J M, Duvic M. Association of erythrodermic cutaneous T cell lymphoma, superantigen-positive staphylococcus aureus, and oligoclonal T-cell receptor Vb gene expansion. Blood 1997; 89: 32–40
- Kim E J, Hess S, Richardson S K, Newton S, Showe L C, Benoit B M, et al. Immunopathogenesis and therapy of cutaneous T cell lymphoma. J Clin Invest 2005; 115: 798–812